Impact of a Mobile App (LoAD Calc) on the Calculation of Maximum Safe Doses of Local Anesthetics: Protocol for a Randomized Controlled Trial

被引:0
|
作者
Fubini, Pietro Elias [1 ,2 ]
Savoldelli, Georges Louis [1 ,2 ]
Beckmann, Tal Sara [1 ,2 ]
Samer, Caroline Flora [2 ,3 ]
Suppan, Melanie [4 ,5 ]
机构
[1] Geneva Univ Hosp, Dept Anesthesiol Clin Pharmacol Intens Care & Emer, Div Anesthesiol, Geneva, Switzerland
[2] Fac Med, Geneva, Switzerland
[3] Geneva Univ Hosp, Dept Anesthesiol Clin Pharmacol Intens Care & Emer, Clin Pharmacol & Toxicol Div, Geneva, Switzerland
[4] Geneva Univ Hosp, Dept Anesthesiol Clin Pharmacol Intens Care & Emer, Div Anesthesiol, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland
[5] Fac Med, Rue Gabrielle Perret Gentil 4, CH-1211 Geneva, Switzerland
来源
JMIR RESEARCH PROTOCOLS | 2024年 / 13卷
关键词
dose calculation; drug safety; information systems research; local anesthetic systemic toxicity; local anesthetics; mobile health app; study protocol; toxicity; SYSTEMIC TOXICITY;
D O I
10.2196/53679
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: Local anesthetics (LAs) are regularly used to alleviate pain during medical or surgical procedures. Their use is generally considered safe, but exceeding the maximum recommended doses can lead to LA systemic toxicity, a rare but potentially lethal complication. Determining maximum safe doses is therefore mandatory before performing local anesthesia, but rules are often unclear and the factors affecting dose calculation are numerous. Mobile health apps have been shown to help clinical decision-making, but most currently available apps present significant limitations. The Local Anesthetics Dose Calculator (LoAD Calc) app was designed to overcome these limitations by taking all relevant parameters into account. Before deploying this app in a clinical setting, it should be tested to determine its effectiveness and whether clinicians would be willing to use it. Objective: The primary objective will be to evaluate the effectiveness of the LoAD Calc app through written simulated cases. The secondary objective will be to determine whether physicians find this app easier, faster, and safer than the methods they generally use. Methods: We describe a parallel-group randomized controlled trial protocol. Anesthesiologists working at the Geneva University Hospitals will be invited to participate. Participants will be asked to compute the maximum dose of LA in 10 simulated clinical cases using 3 different LAs. The maximum safe dose will be determined manually using the same calculation rules that were used to develop LoAD Calc, without using the app itself. An overdose will be considered any dose higher than the correct dose, rounded to the superior integer, while an underdose will be defined as the optimal calculated dose minus 20%, rounded to the inferior integer. Randomization will be stratified according to current position (resident vs registrar). The participants allocated to the LoAD Calc (experimental) group will use the LoAD Calc app to compute the maximum safe LA doses. Those allocated to the control group will be asked to use the method they generally use. The primary outcome will be the overall overdose rate. Secondary outcomes will include the overdose rate according to ideal and actual body weight and to each specific LA, the overall underdose rate, and the time taken to complete these calculations. The app's usability will also be assessed. Results: A sample size of 46 participants will be needed to detect a difference of 10% with a power of 90%. Thus, a target of 50 participants was set to allow for attrition and exclusion criteria. We expect recruitment to begin during the winter of 2023, data analysis in the spring of 2024, and results by the end of 2024. Conclusions: This study should determine whether LoAD Calc, a mobile health app designed to compute maximum safe LA doses, is safer and more efficient than traditional LA calculation methods.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] A mobile app using therapeutic exercise and education for self-management in patients with hand rheumatoid arthritis: a randomized controlled trial protocol
    Rodriguez-Sanchez-Laulhe, Pablo
    Gabriel Luque-Romero, Luis
    Blanquero, Jesus
    Suero-Pineda, Alejandro
    Biscarri-Carbonero, Angela
    Jose Barrero-Garcia, Francisco
    Marcos Heredia-Rizo, Alberto
    TRIALS, 2020, 21 (01)
  • [32] A mobile app using therapeutic exercise and education for self-management in patients with hand rheumatoid arthritis: a randomized controlled trial protocol
    Pablo Rodríguez-Sánchez-Laulhé
    Luis Gabriel Luque-Romero
    Jesús Blanquero
    Alejandro Suero-Pineda
    Ángela Biscarri-Carbonero
    Francisco José Barrero-García
    Alberto Marcos Heredia-Rizo
    Trials, 21
  • [33] Feasibility, Usability, and Safety of ParaGym, an Intelligent Mobile Exercise App for Individuals With Paraplegia: Protocol for a Pilot Block-Randomized Controlled Trial
    Bolz, Janika
    Loescher, Adrian
    Muhl, Rainer
    Badke, Andreas
    Predel, Hans-Georg
    Perret, Claudio
    JMIR RESEARCH PROTOCOLS, 2023, 12
  • [34] Weight loss before total joint arthroplasty using a remote dietitian and mobile app: study protocol for a multicenter randomized, controlled trial
    Michael W. Seward
    Brielle J. Antonelli
    Nancy Giunta
    Richard Iorio
    Wolfgang Fitz
    Jeffrey K. Lange
    Vivek M. Shah
    Antonia F. Chen
    Journal of Orthopaedic Surgery and Research, 15
  • [35] The impact of a mobile app-based corporate sleep health improvement program on productivity: Validation through a randomized controlled trial
    Kawata, Yuji
    Kuroda, Sachiko
    Owan, Hideo
    PLOS ONE, 2023, 18 (10):
  • [36] A mobile app to support self-management and remotely monitor disease impact in rheumatoid arthritis: the randomized controlled AEGORA trial
    Doumen, Michael
    De Meyst, Elias
    Bertrand, Delphine
    Pazmino, Sofia
    Piessens, Marine
    Joly, Johan
    Devinck, Mieke
    Westhovens, Rene
    Verschueren, Patrick
    RHEUMATOLOGY, 2024,
  • [37] The Impact of User Engagement With Exposure Components on Posttraumatic Stress Symptoms in an mHealth Mobile App: Secondary Analysis of a Randomized Controlled Trial
    Davis, C. Adrian
    Miller, Madeleine
    McLean, Carmen P.
    JMIR MHEALTH AND UHEALTH, 2024, 12
  • [38] The Impact of Mobile Health Use on the Self-care of Patients With Type 2 Diabetes: Protocol for a Randomized Controlled Trial
    Gosak, Lucija
    Pajnkihar, Majda
    Stiglic, Gregor
    JMIR RESEARCH PROTOCOLS, 2022, 11 (06):
  • [39] A Mobile Health Intervention (LifeBuoy App) to Help Young People Manage Suicidal Thoughts: Protocol for a Mixed-Methods Randomized Controlled Trial
    Han, Jin
    McGillivray, Lauren
    Wong, Quincy J. J.
    Werner-Seidler, Aliza
    Wong, Iana
    Calear, Alison
    Christensen, Helen
    Torok, Michelle
    JMIR RESEARCH PROTOCOLS, 2020, 9 (10):
  • [40] Development and Testing of a Mobile App for Management of Gestational Diabetes in Nepal: Protocol for a User-Centered Design Study and Exploratory Randomized Controlled Trial
    Berube, Lauren T.
    Shrestha, Archana
    Shrestha, Abha
    Daneault, Jean-Francois
    Shakya, Prabin Raj
    Dhimal, Meghnath
    Shrestha, Roman
    Rawal, Shristi
    JMIR RESEARCH PROTOCOLS, 2024, 13